SecBot SecBot
SC 13G ·Filed Sep 18, 2026

XBIO

Xenetic Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0002103370-26-000003
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future amendments to this SC 13G that disclose an actual stake, as the current filing reports zero beneficial ownership. No immediate trading catalyst.

DirectionNeutral
Confidencemedium
Horizonimmediate
Latest settled — T+20d
XBIO ▼ -28.16% at T+20d
NEUTRAL call -28.16% · α vs SPY -28.36% · entry $2.77 → $1.99
Next anchor: T+60d in 7w
Latest observation: T+25 -29.54% FF3 residual α
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
+7.94%
call +7.94% · α +6.39%
$2.99
settled 5w ago
T+5d
-13.72%
call -13.72% · α -14.99%
$2.39
settled 5w ago
T+20d
-28.16%
call -28.16% · α -28.36%
$1.99
settled 12d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

MJL Manager LLC and its control person Michael Liu filed a Schedule 13G disclosing a passive stake in Xenetic Biosciences, Inc. The filing reports zero shares beneficially owned, indicating no current ownership position. This appears to be a placeholder or corrective filing with no material trading signal.

Key Financial Metrics

Stake
0%
Stake Value
$0.00
Investor
MJL Manager LLC

Key Facts

  • MJL Manager LLC and Michael Liu filed a Schedule 13G on 2026-09-18
  • The filing reports 0 shares beneficially owned, representing 0% of shares outstanding
  • The filing is marked as passive under Rule 13d-1(c) with no intent to influence control
  • A prior SC 13G by MJL Manager LLC was filed on 2026-05-29, also reporting 0 shares
  • Renaissance Technologies LLC filed a separate SC 13G/A on 2026-05-14, but its stake details are not provided in this filing

Financial Impact

No financial impact — zero shares reported

Risk Factors

  • Filing may be a placeholder or administrative correction with no economic substance
  • Lack of disclosed share count limits actionable analysis

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0002103370-26-000003
Document: 0002103370-26-000003-index.html0002103370-26-000003
Document: 0002103370-26-000003.txt0002103370-26-000003
7 reports for XBIO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XBIO — sortable, filterable
TypeNow
Sep 23, 2026
4w ago
8-K
NEUTRAL ★ 5/10
$2.47 $1.93▼ −21.86%▼ −21.44%$1.85 (−25.10%)
Sep 18, 2026
5w ago
SC 13G
NEUTRAL ★ 2/10
$2.77 $1.99▼ −28.16%▼ −28.36%$1.85 (−33.21%)
Sep 16, 2026
5w ago
8-K
BULLISH ★ 7/10
$2.19 $2.10▼ −4.11%▼ −7.29%$1.85 (−15.53%)
Aug 7, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$3.17 $4.67▲ +47.32%▲ +47.72%$1.85 (−41.64%)
May 13, 2026
23w ago
8-K
NEUTRAL ★ 3/10
$3.18 $3.00▼ −5.66%▼ −5.05%$1.85 (−41.82%)
Apr 24, 2026
26w ago
10-K/A
NEUTRAL ★ 3/10
$3.03 $3.07▲ +1.18%▼ −3.77%$1.85 (−38.94%)
Apr 24, 2026
26w ago
8-K
NEUTRAL ★ 3/10
$3.03 $3.07▲ +1.18%▼ −3.77%$1.85 (−38.94%)
Showing 7 of 7

US Market Status

Market Closed — Opens Thu (12h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026